1.Date of occurrence of the event:2022/08/08
2.Company name:OBI Pharma Inc.
3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office
4.Reciprocal shareholding ratios:Not applicable.
5.Cause of occurrence:
(1)The Annual Shareholders’ Meeting of the Company resolved the issuance of restricted stock awards of a total of 500,000 common shares, each with a par value of NT$10, for a total amount of NT$5,000,000 on 2022/6/27. The issuance of restricted stock awards was approved by the Financial Supervisory Commission on 2022/7/12, approval letter No. 1110348619.
(2)The Company’s Board of Directors resolved employees and amount granted for the first issuance of restricted stock awards on 2022/8/8. The total shares issued are 160,000 shares. The Chairman was authorized to decide record date, issuance date, and any other matters not covered herein.
6.Countermeasures:None
7.Any other matters that need to be specified:None